Screening and monitoring both get mentioned in these presentations - but its confusing why and how these terms get used.
Clearly they have 2 massively different implications.
For example in breast cancer - Screening is for any woman (to check for incidence) - whilst monitoring is only for those who have been diagnosed (to chart their recovery).
Hugely different addressable markets!!!
Check out the timelines in the decks - only talk about breast and ovarian monitoring.
But elsewhere they mention screening.
On another line in the timeline they mention pan-cancer screening.
Anybody not confused by this?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
39.3¢ |
Change
0.013(3.29%) |
Mkt cap ! $42.97M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 39.3¢ | 38.5¢ | $7.111K | 18.41K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22641 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 20000 | 1 |
View Market Depth
| Last trade - 12.26pm 18/09/2025 (20 minute delay) ? |
| IIQ (ASX) Chart |